Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

208 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Immune Checkpoint Inhibitors and Cardiac Toxicity: An Emerging Issue.
Varricchi G, Marone G, Mercurio V, Galdiero MR, Bonaduce D, Tocchetti CG. Varricchi G, et al. Among authors: bonaduce d. Curr Med Chem. 2018;25(11):1327-1339. doi: 10.2174/0929867324666170407125017. Curr Med Chem. 2018. PMID: 28403786 Review.
Cardiotoxicity of immune checkpoint inhibitors.
Varricchi G, Galdiero MR, Marone G, Criscuolo G, Triassi M, Bonaduce D, Marone G, Tocchetti CG. Varricchi G, et al. Among authors: bonaduce d. ESMO Open. 2017 Oct 26;2(4):e000247. doi: 10.1136/esmoopen-2017-000247. eCollection 2017. ESMO Open. 2017. PMID: 29104763 Free PMC article. Review.
Pharmacovigilating cardiotoxicity of immune checkpoint inhibitors.
Varricchi G, Galdiero MR, Mercurio V, Bonaduce D, Marone G, Tocchetti CG. Varricchi G, et al. Among authors: bonaduce d. Lancet Oncol. 2018 Dec;19(12):1545-1546. doi: 10.1016/S1470-2045(18)30622-3. Epub 2018 Nov 12. Lancet Oncol. 2018. PMID: 30442496 No abstract available.
Cardiovascular Toxicity of Immune Checkpoint Inhibitors: Clinical Risk Factors.
Pirozzi F, Poto R, Aran L, Cuomo A, Galdiero MR, Spadaro G, Abete P, Bonaduce D, Marone G, Tocchetti CG, Varricchi G, Mercurio V. Pirozzi F, et al. Among authors: bonaduce d. Curr Oncol Rep. 2021 Jan 7;23(2):13. doi: 10.1007/s11912-020-01002-w. Curr Oncol Rep. 2021. PMID: 33415405 Free PMC article. Review.
What Is the Cardiac Impact of Chemotherapy and Subsequent Radiotherapy in Lymphoma Patients?
Mercurio V, Cuomo A, Della Pepa R, Ciervo D, Cella L, Pirozzi F, Parrella P, Campi G, Franco R, Varricchi G, Abete P, Marone G, Petretta M, Bonaduce D, Pacelli R, Picardi M, Tocchetti CG. Mercurio V, et al. Among authors: bonaduce d. Antioxid Redox Signal. 2019 Nov 20;31(15):1166-1174. doi: 10.1089/ars.2019.7842. Epub 2019 Sep 23. Antioxid Redox Signal. 2019. PMID: 31436110
The novel butyrate derivative phenylalanine-butyramide protects from doxorubicin-induced cardiotoxicity.
Russo M, Guida F, Paparo L, Trinchese G, Aitoro R, Avagliano C, Fiordelisi A, Napolitano F, Mercurio V, Sala V, Li M, Sorriento D, Ciccarelli M, Ghigo A, Hirsch E, Bianco R, Iaccarino G, Abete P, Bonaduce D, Calignano A, Berni Canani R, Tocchetti CG. Russo M, et al. Among authors: bonaduce d. Eur J Heart Fail. 2019 Apr;21(4):519-528. doi: 10.1002/ejhf.1439. Epub 2019 Mar 6. Eur J Heart Fail. 2019. PMID: 30843309 Free article.
Commentary on "Functional Improvement After Outpatient Cardiac Rehabilitation in Acute Coronary Syndrome Patients is not Related to Improvement in Left Ventricular Ejection Fraction".
Cuomo A, D'Angelo G, Mercurio V, Bonaduce D, Tocchetti CG. Cuomo A, et al. Among authors: bonaduce d. High Blood Press Cardiovasc Prev. 2020 Jun;27(3):179-181. doi: 10.1007/s40292-020-00386-x. Epub 2020 May 7. High Blood Press Cardiovasc Prev. 2020. PMID: 32382999 No abstract available.
208 results